The Trump administration is moving to help Medicare patients access more accurate tests for cancer.
The Centers for Medicare and Medicaid Services will now cover Medicare diagnostic lab tests that use DNA testing to determine the best treatment for patients with advanced cancer like patients with stage IV or metastatic cancers.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.